GSA Capital Partners’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Buy |
+27,276
| New | +$358K | 0.03% | 1154 |
|
|
2025
Q1 | – | Sell |
-11,593
| Closed | -$310K | – | 1774 |
|
|
2024
Q4 | $310K | Buy |
+11,593
| New | +$310K | 0.02% | 1183 |
|
|
2024
Q2 | – | Sell |
-74,511
| Closed | -$1.36M | – | 1741 |
|
|
2024
Q1 | $1.36M | Buy |
74,511
+21,851
| +41% | +$399K | 0.11% | 263 |
|
|
2023
Q4 | $576K | Buy |
52,660
+8,696
| +20% | +$95.1K | 0.05% | 703 |
|
|
2023
Q3 | $252K | Buy |
+43,964
| New | +$252K | 0.02% | 1176 |
|
|
2023
Q1 | – | Sell |
-26,367
| Closed | -$236K | – | 1591 |
|
|
2022
Q4 | $236K | Sell |
26,367
-1,021
| -4% | -$9.14K | 0.03% | 1084 |
|
|
2022
Q3 | $269K | Buy |
27,388
+10,076
| +58% | +$99K | 0.04% | 1003 |
|
|
2022
Q2 | $138K | Buy |
+17,312
| New | +$138K | 0.02% | 1167 |
|